| 6.3 0.33 (5.53%) | 05-31 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 28.74 | 1-year : | 33.57 |
| Resists | First : | 24.61 | Second : | 28.74 |
| Pivot price | 18.09  |
|||
| Supports | First : | 14.9 | Second : | 8.89 |
| MAs | MA(5) : | 20.68  |
MA(20) : | 16.47 |
| MA(100) : | 17.9 |
MA(250) : | 13.76 |
|
| MACD | MACD : | 0.8 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 64 |
D(3) : | 73.8 |
| RSI | RSI(14): 49.8 |
|||
| 52-week | High : | 32.7 | Low : | 6.01 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CLXT ] has closed below upper band by 49.4%. Bollinger Bands are 51.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 19.81 - 19.95 | 19.95 - 20.05 |
| Low: | 17.2 - 17.37 | 17.37 - 17.5 |
| Close: | 17.95 - 18.18 | 18.18 - 18.37 |
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
Fri, 19 May 2023
Calyxt Announces Stockholder Approval of Merger With Cibus - PR Newswire
Mon, 01 May 2023
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update - PR Newswire
Mon, 24 Apr 2023
Calyxt Completes One-for-Ten Reverse Stock Split - Yahoo Finance
Tue, 18 Apr 2023
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus ... - BioSpace
Fri, 07 Apr 2023
Calyxt Announces Effective Date of Reverse Stock Split - PR Newswire
Tue, 17 Jan 2023
Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 0 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 2.49e+006 (%) |
| Held by Institutions | 49.9 (%) |
| Shares Short | 37 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.909e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -12 % |
| Return on Assets (ttm) | 421.5 % |
| Return on Equity (ttm) | -44.3 % |
| Qtrly Rev. Growth | 167000 % |
| Gross Profit (p.s.) | 15.29 |
| Sales Per Share | -92.91 |
| EBITDA (p.s.) | 76960.8 |
| Qtrly Earnings Growth | -3.9 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -15 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.2 |
| Price to Cash Flow | 68.71 |
| Dividend | 0 |
| Forward Dividend | 118110 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|